20524177|t|Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia.
20524177|a|This project was done in order to determine why the annual incidence of metoclopramide-associated tardive dyskinesia is much higher than that for the commonly used antipsychotics. To test the hypothesis that metoclopramide tardive dyskinesia may be associated with high concentrations of metoclopramide in the substantia nigra under clinical conditions, the nonspecific binding of tritiated antipsychotics to the dissected melaninized regions of postmortem human substantia nigra was measured. The nonspecific binding at 1 nM [3H]ligand was 7.3, 4.2, 2.6, 0.91 and 0.66 fmoles/mg for [3H]haloperidol, [3H]clozapine, [3H]raclopride, [3H]metoclopramide, and [3H]olanzapine, respectively. After adjusting these values for the known free concentrations of these drugs in plasma or spinal fluid, the amounts that would be bound under clinical conditions would be 231, 113, 15, 11, and 3.4 fmoles/mg for metoclopramide, clozapine, raclopride, haloperidol, and olanzapine, respectively. Using rat striatum as baseline to define antipsychotic binding to nonnigral tissue, the excess amount of binding to the Alzheimer nigral tissue under clinical conditions would be 209, 19, 0, 3.4 and 0.8 fmole/mg for metoclopramide, clozapine, raclopride, haloperidol, and olanzapine, respectively, with a similar pattern for nigral tissues from Huntington and Multiple Sclerosis patients. The high accumulation of metoclopramide is sufficiently high to cause nigral nerve cell membrane damage by metoclopramide's detergent-like action, possibly explaining metoclopramide's toxic ability to elicit early tardive dyskinesia. In addition, the nonspecific binding of metoclopramide was much higher in Alzheimer-diseased substantia nigra, consistent with the fact that older individuals are relatively more vulnerable to metoclopramide tardive dyskinesia.
20524177	75	89	metoclopramide	Chemical	MESH:D008787
20524177	123	142	Alzheimer's disease	Disease	MESH:D000544
20524177	144	164	Huntington's disease	Disease	MESH:D006816
20524177	170	188	Multiple Sclerosis	Disease	MESH:D009103
20524177	189	197	patients	Species	9606
20524177	219	237	tardive dyskinesia	Disease	MESH:D004409
20524177	311	325	metoclopramide	Chemical	MESH:D008787
20524177	337	355	tardive dyskinesia	Disease	MESH:D004409
20524177	447	461	metoclopramide	Chemical	MESH:D008787
20524177	462	480	tardive dyskinesia	Disease	MESH:D004409
20524177	527	541	metoclopramide	Chemical	MESH:D008787
20524177	620	644	tritiated antipsychotics	Chemical	-
20524177	696	701	human	Species	9606
20524177	765	775	[3H]ligand	Chemical	-
20524177	827	838	haloperidol	Chemical	MESH:D006220
20524177	844	853	clozapine	Chemical	MESH:D003024
20524177	859	869	raclopride	Chemical	MESH:D020891
20524177	875	889	metoclopramide	Chemical	MESH:D008787
20524177	899	909	olanzapine	Chemical	MESH:D000077152
20524177	1137	1151	metoclopramide	Chemical	MESH:D008787
20524177	1153	1162	clozapine	Chemical	MESH:D003024
20524177	1164	1174	raclopride	Chemical	MESH:D020891
20524177	1176	1187	haloperidol	Chemical	MESH:D006220
20524177	1193	1203	olanzapine	Chemical	MESH:D000077152
20524177	1225	1228	rat	Species	10116
20524177	1339	1348	Alzheimer	Disease	MESH:D000544
20524177	1435	1449	metoclopramide	Chemical	MESH:D008787
20524177	1451	1460	clozapine	Chemical	MESH:D003024
20524177	1462	1472	raclopride	Chemical	MESH:D020891
20524177	1474	1485	haloperidol	Chemical	MESH:D006220
20524177	1491	1501	olanzapine	Chemical	MESH:D000077152
20524177	1564	1574	Huntington	Disease	MESH:D006816
20524177	1579	1597	Multiple Sclerosis	Disease	MESH:D009103
20524177	1598	1606	patients	Species	9606
20524177	1633	1647	metoclopramide	Chemical	MESH:D008787
20524177	1696	1704	membrane	Disease	MESH:D015433
20524177	1715	1729	metoclopramide	Chemical	MESH:D008787
20524177	1775	1789	metoclopramide	Chemical	MESH:D008787
20524177	1822	1840	tardive dyskinesia	Disease	MESH:D004409
20524177	1882	1896	metoclopramide	Chemical	MESH:D008787
20524177	1916	1934	Alzheimer-diseased	Disease	MESH:D000544
20524177	2035	2049	metoclopramide	Chemical	MESH:D008787
20524177	2050	2068	tardive dyskinesia	Disease	MESH:D004409
20524177	Association	MESH:D000077152	MESH:D000544
20524177	Association	MESH:D003024	MESH:D009103
20524177	Association	MESH:D008787	MESH:D009103
20524177	Positive_Correlation	MESH:D008787	MESH:D004409
20524177	Association	MESH:D020891	MESH:D000544
20524177	Association	MESH:D008787	MESH:D000544
20524177	Negative_Correlation	MESH:D003024	MESH:D000544
20524177	Association	MESH:D008787	MESH:D015433
20524177	Association	MESH:D008787	MESH:D006816

